Literature DB >> 7488644

Effects of Na+/H+ antiport and intracellular pH in the regulation of HL-60 cell apoptosis.

W H Zhu1, T T Loh.   

Abstract

The roles of Na+/H+ antiport and intracellular pH in apoptosis of HL-60 cells were investigated here. We found that dimethyl amiloride, a specific Na+/H+ antiport inhibitor, induced intracellular acidification but not apoptosis; while sodium ionophore, monensin caused intracellular alkalinization as well as apoptosis in HL-60 cells. Br-A23187 and thapsigargin could induce a various degree of intracellular alkalinization through the stimulation of Na+/H+ antiport. Dimethyl amiloride blocked the intracellular alkalinization and inhibited apoptosis induced by Br-A23187 and thapsigargin. PMA also stimulated Na+/H+ antiport and induced intracellular alkalinization which was completely blocked by dimethyl amiloride and partially attenuated by PKC inhibitors. PMA could inhibit apoptosis in HL-60 cells. PMA-induced suppression of apoptosis was, however, not interfered by dimethyl amiloride, but could be abolished by PKC inhibitors. These results indicate that pHi alkalinization and/or the stimulation of Na+/H+ antiport, instead of intracellular acidification, are contributory to the induction of apoptosis. PMA-induced inhibition of apoptosis is not necessarily associated with intracellular alkalinization, but primarily due to activation of PKC. We suggest that stimulation of Na+/H+ antiport and pHi alkalinization act as facilitating factors in the induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488644     DOI: 10.1016/0167-4889(95)00102-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH.

Authors:  A R Khaled; K Kim; R Hofmeister; K Muegge; S K Durum
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Alkaline conditions accelerate polymorphonuclear leukocyte apoptosis in vitro.

Authors:  B Leblebicioglu; J Walters
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 4.  Role of intracellular pH in proliferation, transformation, and apoptosis.

Authors:  L D Shrode; H Tapper; S Grinstein
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

5.  Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii.

Authors:  Erin M Garrison; Gustavo Arrizabalaga
Journal:  Mol Microbiol       Date:  2009-03-04       Impact factor: 3.501

6.  Control of cellular Bcl-xL levels by deamidation-regulated degradation.

Authors:  So Hee Dho; Benjamin E Deverman; Carlo Lapid; Scott R Manson; Lu Gan; Jacob J Riehm; Rajeev Aurora; Ki-Sun Kwon; Steven J Weintraub
Journal:  PLoS Biol       Date:  2013-06-25       Impact factor: 8.029

7.  Rubidium(I) monensinate dihydrate.

Authors:  Sema Öztürk Yıldırım; Vickie McKee; Fatim-Zahra Khardli; Mostafa Mimouni; Taibi Ben Hadda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2007-12-12

8.  DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.

Authors:  Rui Zhao; David Oxley; Trevor S Smith; George A Follows; Anthony R Green; Denis R Alexander
Journal:  PLoS Biol       Date:  2007-01       Impact factor: 8.029

Review 9.  Bench-to-bedside review: Permissive hypercapnia.

Authors:  Donall O'Croinin; Martina Ni Chonghaile; Brendan Higgins; John G Laffey
Journal:  Crit Care       Date:  2004-08-05       Impact factor: 9.097

10.  Effect of feed restriction and realimentation with monensin supplementation on placental structure and ultrastructure in anglo-nubian goats.

Authors:  A L Cristofolini; M P Turiello; E G Sanchis; G Cufré; C I Merkis
Journal:  ISRN Vet Sci       Date:  2012-09-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.